News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
-
Oct 9, 2018
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it received the Gold Award in the 2018 Best Employers for Healthy Lifestyles...
-
Oct 5, 2018
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2018 results on Tuesday, October 23, 2018,...
-
Oct 5, 2018
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced an agreement to sell its India medical diagnostics business to Strand Life Sciences,...
-
Sep 27, 2018PhenoPath deepens Quest's presence in the Pacific Northwest while extending the company's capabilities in anatomic pathology and molecular oncology
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has acquired PhenoPath, a national provider of specialized anatomic...
Sep 26, 2018Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Regional Medical Center Health System (RMC), a regional health care provider for a five-county...
-
Sep 25, 2018Acquisition to broaden access to tuberculosis (TB) IGRA blood testing in the United States
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today...
-
Sep 24, 2018Bolsters Quest's leadership in advanced diagnostics for women's and reproductive health
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired ReproSource, a national leader in specialty fertility diagnostic...
-
Sep 7, 2018
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare...
Sep 6, 2018- More than half of Americans tested misused their prescription drugs in 2017More than half (52 percent) of Americans tested in 2017 misused their prescription drugs, the same rate as in 2016, but the epidemic is shifting beyond prescription opioids to encompass other...
-
Aug 17, 2018
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share,...